These results suggest that comprehensive genetic testing of the RAD51C and RAD51D genes in OC patients should not be limited only to high-risk OC patients with an apparent family history, and an analysis of all OC patients should be considered irrespectively to the family cancer history and age of onset [26]. The gene discussed is RAD51D; the disease is cancer.